BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31324936)

  • 1. Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents.
    Kanen JW; Ersche KD; Fineberg NA; Robbins TW; Cardinal RN
    Psychopharmacology (Berl); 2019 Aug; 236(8):2337-2358. PubMed ID: 31324936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Learning From Negative Feedback in Stimulant Use Disorder: Dopaminergic Modulation.
    Lim TV; Cardinal RN; Bullmore ET; Robbins TW; Ersche KD
    Int J Neuropsychopharmacol; 2021 Nov; 24(11):867-878. PubMed ID: 34197589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
    Ersche KD; Roiser JP; Abbott S; Craig KJ; Müller U; Suckling J; Ooi C; Shabbir SS; Clark L; Sahakian BJ; Fineberg NA; Merlo-Pich EV; Robbins TW; Bullmore ET
    Biol Psychiatry; 2011 Oct; 70(8):754-762. PubMed ID: 21967987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.
    Morein-Zamir S; Craig KJ; Ersche KD; Abbott S; Muller U; Fineberg NA; Bullmore ET; Sahakian BJ; Robbins TW
    Psychopharmacology (Berl); 2010 Oct; 212(3):357-67. PubMed ID: 20661550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder.
    Murray GK; Knolle F; Ersche KD; Craig KJ; Abbott S; Shabbir SS; Fineberg NA; Suckling J; Sahakian BJ; Bullmore ET; Robbins TW
    Psychopharmacology (Berl); 2019 Aug; 236(8):2325-2336. PubMed ID: 31201476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2-like receptor stimulation blocks negative feedback in visual and spatial reversal learning in the rat: behavioural and computational evidence.
    Alsiö J; Phillips BU; Sala-Bayo J; Nilsson SRO; Calafat-Pla TC; Rizwand A; Plumbridge JM; López-Cruz L; Dalley JW; Cardinal RN; Mar AC; Robbins TW
    Psychopharmacology (Berl); 2019 Aug; 236(8):2307-2323. PubMed ID: 31218428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior.
    Boulougouris V; Castañé A; Robbins TW
    Psychopharmacology (Berl); 2009 Mar; 202(4):611-20. PubMed ID: 18836703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence.
    Ersche KD; Bullmore ET; Craig KJ; Shabbir SS; Abbott S; Müller U; Ooi C; Suckling J; Barnes A; Sahakian BJ; Merlo-Pich EV; Robbins TW
    Arch Gen Psychiatry; 2010 Jun; 67(6):632-44. PubMed ID: 20530013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal modulation of reward versus punishment learning by a dopamine D2-receptor antagonist in pathological gamblers.
    Janssen LK; Sescousse G; Hashemi MM; Timmer MH; ter Huurne NP; Geurts DE; Cools R
    Psychopharmacology (Berl); 2015 Sep; 232(18):3345-53. PubMed ID: 26092311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from event-related potentials and computational modeling of striatal-cortical function.
    Santesso DL; Evins AE; Frank MJ; Schetter EC; Bogdan R; Pizzagalli DA
    Hum Brain Mapp; 2009 Jul; 30(7):1963-76. PubMed ID: 18726908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness.
    Pizzagalli DA; Evins AE; Schetter EC; Frank MJ; Pajtas PE; Santesso DL; Culhane M
    Psychopharmacology (Berl); 2008 Feb; 196(2):221-32. PubMed ID: 17909750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociable dopaminergic and pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCD.
    Eagle DM; Schepisi C; Chugh S; Desai S; Han SYS; Huang T; Lee JJ; Sobala C; Ye W; Milton AL; Robbins TW
    Psychopharmacology (Berl); 2020 Dec; 237(12):3569-3581. PubMed ID: 32886158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Environmental Uncertainty With Altered Decision-making and Learning Mechanisms in Youths With Obsessive-Compulsive Disorder.
    Marzuki AA; Tomic I; Ip SHY; Gottwald J; Kanen JW; Kaser M; Sule A; Conway-Morris A; Sahakian BJ; Robbins TW
    JAMA Netw Open; 2021 Nov; 4(11):e2136195. PubMed ID: 34842925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder.
    Remijnse PL; Nielen MM; van Balkom AJ; Cath DC; van Oppen P; Uylings HB; Veltman DJ
    Arch Gen Psychiatry; 2006 Nov; 63(11):1225-36. PubMed ID: 17088503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
    Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
    Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T; Clarke PB
    Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder.
    Denys D; de Vries F; Cath D; Figee M; Vulink N; Veltman DJ; van der Doef TF; Boellaard R; Westenberg H; van Balkom A; Lammertsma AA; van Berckel BN
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1423-31. PubMed ID: 23876376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD.
    Eagle DM; Noschang C; d'Angelo LS; Noble CA; Day JO; Dongelmans ML; Theobald DE; Mar AC; Urcelay GP; Morein-Zamir S; Robbins TW
    Behav Brain Res; 2014 May; 264(100):207-29. PubMed ID: 24406720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compulsivity in obsessive-compulsive disorder and addictions.
    Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
    Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.